| Q2 2025 | 90 | $791M | +$146M | -$222M | -$75.2M | LLY, BSX, VRTX, GKOS, ISRG | 13F-HR | 8/13/2025, 06:18 AM | 
          
            | Q1 2025 | 94 | $870M | +$165M | -$271M | -$107M | UNH, LLY, VRTX, MCK, BSX | 13F-HR | 5/14/2025, 07:00 AM | 
          
            | Q4 2024 | 92 | $973M | +$100M | -$237M | -$137M | BSX, LLY, PRCT, ISRG, REGN | 13F-HR | 2/13/2025, 06:16 AM | 
          
            | Q3 2024 | 95 | $1.23B | +$247M | -$141M | +$106M | BSX, UNH, LLY, REGN, THC | 13F-HR | 11/13/2024, 06:10 AM | 
          
            | Q2 2024 | 93 | $1.04B | +$184M | -$173M | +$11.3M | UNH, ELV, BSX, LLY, REGN | 13F-HR | 8/13/2024, 07:00 AM | 
          
            | Q1 2024 | 84 | $1.06B | +$265M | -$325M | -$59.4M | CI, LLY, THC, BSX, ELV | 13F-HR | 5/14/2024, 06:09 AM | 
          
            | Q4 2023 | 85 | $1B | +$186M | -$216M | -$30M | MDT, LLY, BSX, VRTX, REGN | 13F-HR | 2/13/2024, 09:24 AM | 
          
            | Q3 2023 | 87 | $928M | +$106M | -$64.1M | +$42.1M | LLY, BSX, BMRN, REGN, MCK | Restatement | 11/13/2023, 06:08 AM | 
          
            | Q2 2023 | 83 | $949M | +$196M | -$135M | +$61.4M | LLY, BMRN, CI, BSX, MCK | 13F-HR | 8/11/2023, 06:10 AM | 
          
            | Q1 2023 | 87 | $909M | +$145M | -$92.5M | +$52.4M | UNH, BSX, REGN, VRTX, ELV | 13F-HR | 5/11/2023, 06:57 PM | 
          
            | Q4 2022 | 93 | $958M | +$105M | -$67M | +$37.8M | LLY, COR, MDT, BSX, REGN | 13F-HR | 2/13/2023, 05:26 AM | 
          
            | Q3 2022 | 80 | $863M | +$130M | -$96.3M | +$33.6M | LLY, UNH, BSX, VRTX, TMO | 13F-HR | 11/14/2022, 03:36 PM | 
          
            | Q2 2022 | 86 | $880M | +$112M | -$96.2M | +$16.3M | CI, LLY, ABBV, UNH, PFE | 13F-HR | 8/12/2022, 08:00 AM | 
          
            | Q1 2022 | 89 | $1.01B | +$78.8M | -$471M | -$393M | LLY, HZNP, ABBV, UNH, MCK | 13F-HR | 5/13/2022, 04:32 PM | 
          
            | Q4 2021 | 92 | $1.5B | +$170M | -$109M | +$61.3M | UNH, PFE, LLY, HZNP, ELV | 13F-HR | 2/11/2022, 05:09 AM | 
          
            | Q3 2021 | 92 | $1.42B | +$198M | -$172M | +$25.4M | HZNP, UNH, ELV, JNJ, PFE | 13F-HR | 11/12/2021, 06:05 AM | 
          
            | Q2 2021 | 94 | $1.47B | +$220M | -$245M | -$25.1M | UNH, HZNP, VRTX, JAZZ, ELV | 13F-HR | 8/13/2021, 06:12 AM | 
          
            | Q1 2021 | 92 | $1.43B | +$312M | -$137M | +$174M | HZNP, JNJ, UNH, JAZZ, ABBV | 13F-HR | 5/14/2021, 06:01 AM | 
          
            | Q4 2020 | 83 | $1.23B | +$231M | -$162M | +$69.5M | ABBV, BMRN, HZNP, MDT, UNH | 13F-HR | 1/19/2021, 09:56 AM | 
          
            | Q3 2020 | 82 | $1.12B | +$187M | -$47.8M | +$139M | BMRN, HZNP, NVCR, UNH, VRTX | 13F-HR | 10/13/2020, 12:17 PM | 
          
            | Q2 2020 | 94 | $926M | +$117M | -$114M | +$3.09M | HZNP, VRTX, UNH, ABBV, BMRN | 13F-HR | 7/16/2020, 10:38 AM | 
          
            | Q1 2020 | 85 | $714M | +$88.5M | -$58.6M | +$29.9M | HZNP, VRTX, ABBV, NVCR, UNH | 13F-HR | 4/16/2020, 11:17 AM | 
          
            | Q4 2019 | 94 | $913M | +$137M | -$145M | -$8.91M | ESPR, VRTX, NVCR, HZNP, HUM | 13F-HR | 1/17/2020, 03:30 PM | 
          
            | Q3 2019 | 92 | $792M | +$128M | -$98.3M | +$29.5M | VRTX, HZNP, NVCR, ALXN, ESPR | 13F-HR | 10/16/2019, 06:05 AM | 
          
            | Q2 2019 | 87 | $882M | +$139M | -$52.2M | +$86.7M | VRTX, HUM, JAZZ, ALXN, NKTR | 13F-HR | 7/22/2019, 04:38 PM | 
          
            | Q1 2019 | 93 | $855M | +$115M | -$179M | -$63.7M | UNH, JAZZ, VRTX, ABMD, CI | 13F-HR | 4/11/2019, 06:14 AM | 
          
            | Q4 2018 | 89 | $875M | +$173M | -$59.7M | +$114M | UNH, CI, MDT, CVS, BDX | 13F-HR | 2/5/2019, 08:55 AM | 
          
            | Q3 2018 | 88 | $998M | +$109M | -$147M | -$37.2M | CIXXXX, CVS, ALXN, VRTX, INCY | 13F-HR | 10/3/2018, 07:33 AM | 
          
            | Q2 2018 | 89 | $977M | +$229M | -$73.1M | +$156M | NKTR, HZNPXXXX, VRTX, INCY, ABMD | 13F-HR | 7/20/2018, 09:42 AM | 
          
            | Q1 2018 | 92 | $811M | +$163M | -$82.1M | +$81.1M | HZNPXXXX, CELG, ALXN, VRTX, JAZZ | 13F-HR | 4/11/2018, 09:56 AM | 
          
            | Q4 2017 | 95 | $740M | +$115M | -$168M | -$53.2M | HZNPXXXX, ESPR, ADMS, EXEL, VRTX | 13F-HR | 1/19/2018, 03:10 PM | 
          
            | Q3 2017 | 93 | $783M | +$195M | -$78.5M | +$116M | HZNPXXXX, VRTX, EXEL, ABMD, ALXN | 13F-HR | 10/13/2017, 05:02 PM | 
          
            | Q2 2017 | 108 | $696M | +$156M | -$105M | +$51.3M | HZNPXXXX, EXEL, NVCR, ALXN, CELG | 13F-HR | 7/11/2017, 09:02 AM | 
          
            | Q1 2017 | 104 | $631M | +$141M | -$54.6M | +$86M | HZNPXXXX, ESPR, BIIB, GKOS, AMGN | 13F-HR | 4/19/2017, 09:51 AM | 
          
            | Q4 2016 | 108 | $522M | +$116M | -$84.7M | +$31.4M | GILD, BMY, AGN, LLY, MDT | 13F-HR | 1/13/2017, 08:05 AM | 
          
            | Q3 2016 | 106 | $603M | +$148M | -$76.4M | +$71.3M | LLY, ALXN, CELG, AGN, UNH | 13F-HR | 11/8/2016, 07:37 AM | 
          
            | Q2 2016 | 97 | $563M | +$129M | -$67.8M | +$61.2M | ALXN, GILD, CELG, BIIB, LLY | 13F-HR | 8/1/2016, 11:22 AM | 
          
            | Q1 2016 | 92 | $504M | +$89.9M | -$110M | -$20.5M | ALXN, GILD, BMRN, PFE, LLY | 13F-HR | 4/19/2016, 06:51 AM | 
          
            | Q4 2015 | 96 | $661M | +$114M | -$101M | +$12.9M | PRGO, ABMD, MDT, ALXN, CVS | 13F-HR | 1/19/2016, 09:13 AM | 
          
            | Q3 2015 | 91 | $627M | +$175M | -$78.8M | +$95.9M | AMGN, ALXN, MDT, UNH, LLY | 13F-HR | 10/26/2015, 09:44 AM | 
          
            | Q2 2015 | 96 | $833M | +$321M | -$37.5M | +$284M | UNH, ALXN, ALKS, BIIB, CVS | 13F-HR | 7/30/2015, 09:55 AM | 
          
            | Q1 2015 | 88 | $590M | +$261M | -$21.9M | +$239M | ALXN, CELG, MRK, BIIB, AMGN | 13F-HR | 5/13/2015, 08:07 AM | 
          
            | Q4 2014 | 81 | $333M | +$93M | -$85.6M | +$7.37M | CELG, GILD, CVS, REGN, ABBV | 13F-HR | 2/9/2015, 07:16 AM | 
          
            | Q3 2014 | 96 | $331M | +$86.1M | -$89.6M | -$3.49M | ALKS, UHS, ALXN, BIIB, SLXP | 13F-HR | 11/3/2014, 10:30 AM | 
          
            | Q2 2014 | 96 | $337M | +$98.4M | -$61.6M | +$36.8M | BIIB, F113PS, GILD, ALXN, CELG | 13F-HR | 7/31/2014, 10:46 AM | 
          
            | Q1 2014 | 80 | $305M | +$114M | -$24.6M | +$89.7M | GILD, ALXN, REGN, BIIB, PFE | 13F-HR | 5/14/2014, 09:22 AM | 
          
            | Q4 2013 | 84 | $256M |  |  |  | REGN, CELG, GILD, CVS, BIIB | 13F-HR | 2/14/2014, 09:39 AM |